The COVID-NMA initiative
A living mapping and living systematic review of Covid-19 trials
COVID-NMA is an international research initiative supported by the WHO and Cochrane.
We provide a living mapping of COVID-19 trials. We are also conducting living evidence synthesis on preventive interventions, treatments and vaccines for COVID-19 to assist decision makers.
See the description of our model here and our living review protocol here.
LIVING MAPPING OF TRIALS
(i.e., trials registered on the WHO platform)Updated weekly
3505
Randomized Trials
1656 RCTs recruiting
LIVING SYNTHESIS OF PUBLISHED STUDIES
(include both articles and preprints)Updated daily
483
Studies (RCTs or Observational studies) with complete data extraction and results
included in our evidence synthesis
Weekly update
September 20 to September 24, 2021 : see the update here.
Newsletter
To receive updates on our project, please subscribe below.